Heather Helen Bendall

US Patent:

20090209606, Aug 20, 2009

Filed:

Feb 18, 2009

Appl. No.:

12/372910

Inventors:

Heather Helene Bendall - Del Mar CA, US
Gary T. Elliott - San Diego CA, US
Lorenzo M. Leoni - Lodrino, CH
Christina Carol Niemeyer - Poway CA, US
Pratik S. Multani - San Diego CA, US

International Classification:

A61K 31/4184
A61P 35/00

US Classification:

514394

Abstract:

Methods and compositions for treating cancers characterized by death-resistant cancer cells are described. In general, such methods involve administration of a therapeutically effective amount of a compound that induces mitotic catastrophe in the some, and preferably most or all, of the cancerous cells. Methods for assessing the efficacy of such treatments are also provided.

US Patent:

20060128777, Jun 15, 2006

Filed:

Nov 4, 2005

Appl. No.:

11/267010

Inventors:

Heather Bendall - Del Mar CA, US
Gary Elliott - San Diego CA, US
Lorenzo Leoni - Lodrino, CH
Christina Niemeyer - Poway CA, US
Pratik Multani - San Diego CA, US

International Classification:

A61K 31/4184

US Classification:

514394000

Abstract:

Methods and compositions for treating cancers characterized by death-resistant cancer cells are described. In general, such methods involve administration of a therapeutically effective amount of a compound that induces mitotic catastrophe in the some, and preferably most or all, of the cancerous cells. Methods for assessing the efficacy of such treatments are also provided.